Key Market Indicators
Panama is set to reach a HIV/AIDS treatment coverage of 64% by the year 2026, up from 54% in 2021. This marks an average annual growth of 2.7 points since 2005. In 2021, Panama was ranked 96th, but was overtaken by Barbados at 54%. Cape Verde, Latvia, and Zimbabwe were ranked 2nd, 3rd, and 4th respectively. In terms of HIV/AIDS prevalence, the demand in Panama is expected to grow by 0.7% annually, reaching 539 units (persons) aged 0-14 by 2026. Since 1995, the demand has increased by 0.7%. In 2021, Panama was ranked 80th, with Chile ahead at 517 units (persons). Nigeria, Mozambique, and Tanzania were ranked 2nd, 3rd, and 4th respectively.
